PH284's mechanism of action is claimed to be distinct from existing treatments for appetite loss associated with chronic conditions. Credit: PattyPhoto/Shutterstock. · Clinical Trials Arena · ...

Mr. Smith was a 54-year-old man with advanced non–small-cell lung cancer who had received two cycles of systemic chemotherapy for metastatic disease. He decided to not have any further chemotherapy.

DelveInsight’s ‘Cancer Cachexia Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Cancer Cachexia epidemiology in the 7MM, i.e., the ...

Cachexia – the massive depletion of muscle mass and adipose tissue – is commonly seen in people with cancer and other major illnesses. Also called cancer cachexia or cancer anorexia cachexia, it is a ...

Vistagen (Nasdaq: VTGN), a late clinical-stage company dedicated to pioneering neuroscience based on nose-to-brain neurocircuitry, today announced positive results from an exploratory Phase 2A study ...

Eating disorders are often thought of as body image disorders with symptoms of food restriction and purging. In most cases, the goal of these behaviors is to prevent weight gain. Not all eating ...